A comprehensive view of U.S. Food and Drug Administration (FDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Agriculture Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

High demand for injectable weight-loss drugs has led to supply issues, with most varieties listed in short supply by the FDA; Eli Lilly reports shortages of its Zepbound and Mounjaro could last until 2025
Published: April 19, 2024 by CBS - 12 WJTV (Jackson, MS)
FDA approves Roche's oral Alecensa for ALK-positive early-stage lung cancer treatment following successful Phase 3 trial; trial results show Alecensa reduced the risk of disease recurrence or death by 76%
Published: April 19, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
FDA grants fast track designation to Asklepios BioPharmaceutical's AB-1002, a gene therapy for adults with non-ischemic cardiomyopathy and Class III heart failure symptoms; the therapy is currently in Phase 2 trials
Published: April 18, 2024 by Bayer AG
Boston Scientific recalls Obsidio Conformable Embolic blood flow blocking agent due to safety issues; the product is used to block blood supply to tumors and to treat bleeding in patients
Published: April 18, 2024 by MedTech Dive
Trader Joe’s takes herbs made by a Miami area company off the shelves of stores in 29 states and issues a recall of those already sold after a CDC and FDA investigation links the herbs to a salmonella outbreak
Published: April 18, 2024 by Miami Herald (FL)

Ask us about our Agriculture Industry market view

Trending Chart

Interactive chart with headline count